Value Framework News Today

investigation into hunter biden and doj claims hunter chose not to pay $1.4 million in taxes between 2016 and 2019. instead he used money to fund a lavish lifestyle of parties, drugs, women and adult entertainment. there is new questions emerging about this indictment impact on president biden reelection campaign. one analyst saying it is like a nuclear bomb going off for the bidens. hello, this is "outnumbered," im emily compagno. joining me is tammy bruce, fox business anchor and co-...

Experts have highlighted the need to improve data collection for metastatic breast cancer, end the stigma surrounding the disease, and improve patient outcomes via equitable access to care, individualized treatment, multidisciplinary management, and use of evidence-based guidelines. Many patients with metastatic breast cancer feel abandoned and do not receive appropriate care, according to a report published in The Lancet.

Next-generation data platform powered by lakehouse architecture augments Arcadia’s population health and value-based care capabilities...

Rollout follows privileged access and extensive testing of Microsoft 365 Copilot, saving Avanade employees up to two hours a day within six weeks COMP...

This June, Greater Williamsburg was honored to recognize numerous organizations & individuals in our community at our Annual Meeting and 15 Under 50 Awards…

Amid the energy sector’s transformation, Priscilla Chau, Director – HR, CLP Power Hong Kong, is rebuilding culture by helping the workforce adopt new ways of doing things.

Little by little, the glass ceiling is cracking.

email article Launch prices of cancer drugs over the last decade were substantially higher in the U.S. than in similar, high-income European countries, and the gap only increased in the years after approval, according to an economic analysis. From 2009 to 2019, the median monthly treatment costs for new drugs at launch reached $11,755 in the U.S., as compared to $8,305 in Germany, $6,955 in Switzerland, and $7,355 in England, reported Kerstin N. Vokinger, MD, JD, PhD, of the University of...